User profiles for "author:G Vujanic"
Gordan VujanicSidra Medicine, Doha, Qatar Verified email at sidra.org Cited by 8541 |
[HTML][HTML] Cardiac tumours in children
O Uzun, DG Wilson, GM Vujanic, JM Parsons… - Orphanet journal of rare …, 2007 - Springer
Cardiac tumours are benign or malignant neoplasms arising primarily in the inner lining,
muscle layer, or the surrounding pericardium of the heart. They can be primary or metastatic …
muscle layer, or the surrounding pericardium of the heart. They can be primary or metastatic …
[HTML][HTML] Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol
MM Van Den Heuvel-eibrink, JA Hol… - Nature Reviews …, 2017 - nature.com
Abstract The Renal Tumour Study Group of the International Society of Paediatric Oncology
(SIOP–RTSG) has developed a new protocol for the diagnosis and treatment of childhood …
(SIOP–RTSG) has developed a new protocol for the diagnosis and treatment of childhood …
[HTML][HTML] Wilms tumour
…, CV Fernandez, J Brok, K Nakata, G Vujanic… - Nature Reviews …, 2021 - nature.com
Wilms tumour (WT) is a childhood embryonal tumour that is paradigmatic of the intersection
between disrupted organogenesis and tumorigenesis. Many WT genes play a critical (non …
between disrupted organogenesis and tumorigenesis. Many WT genes play a critical (non …
Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood
GM Vujanić, B Sandstedt, D Harms… - Medical and …, 2002 - Wiley Online Library
Abstract The previous International Society of Paediatric Oncology (SIOP) trials and studies
recognized three prognostic groups of renal tumors of childhood: low risk, intermediate risk …
recognized three prognostic groups of renal tumors of childhood: low risk, intermediate risk …
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome
Background Constitutional DICER1 mutations were recently reported to cause familial
pleuropulmonary blastoma (PPB). Aim To investigate the contribution and phenotypic …
pleuropulmonary blastoma (PPB). Aim To investigate the contribution and phenotypic …
[HTML][HTML] The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
On the basis of the results of previous national and international trials and studies, the Renal
Tumour Study Group of the International Society of Paediatric Oncology (SIOP–RTSG) has …
Tumour Study Group of the International Society of Paediatric Oncology (SIOP–RTSG) has …
Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK …
C Mitchell, K Pritchard-Jones, R Shannon… - European journal of …, 2006 - Elsevier
Purpose: To determine if patients receiving preoperative chemotherapy with vincristine and
actinomycin D for non-metastatic Wilms' tumour have a more advantageous stage …
actinomycin D for non-metastatic Wilms' tumour have a more advantageous stage …
The pathology of Wilms' tumour (nephroblastoma): the International Society of Paediatric Oncology approach
GM Vujanić, B Sandstedt - Journal of clinical pathology, 2010 - jcp.bmj.com
In the International Society of Paediatric Oncology renal tumour trials, preoperative
chemotherapy has been successfully applied with resulting reduction of tumour rupture and …
chemotherapy has been successfully applied with resulting reduction of tumour rupture and …
[HTML][HTML] Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH
A Weirich, I Leuschner, D Harms, GM Vujanic… - Annals of oncology, 2001 - Elsevier
Background: Histologic subtypes of standard histology Wilms' tumor (WT) and the effect of
preoperative therapy on their clinical and histologic features, deserve to be analysed in …
preoperative therapy on their clinical and histologic features, deserve to be analysed in …
[HTML][HTML] Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised …
…, L Boccon-Gibod, I Leuschner, G Vujanic… - The Lancet, 2015 - thelancet.com
Background Before this study started, the standard postoperative chemotherapy regimen for
stage II–III Wilms' tumour pretreated with chemotherapy was to include doxorubicin …
stage II–III Wilms' tumour pretreated with chemotherapy was to include doxorubicin …